Altimmune Inc [ALT] stock prices are up 13.85% to $5.92 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALT shares have gain 6.28% over the last week, with a monthly amount drifted -4.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on January 08, 2025, and set its price target to $18. On November 12, 2024, UBS initiated with a Buy rating and assigned a price target of $26 on the stock. Guggenheim downgraded its rating to a Neutral. Goldman initiated its recommendation with a Neutral and recommended $13 as its price target on January 24, 2024. Goldman downgraded its rating to Neutral for this stock on March 22, 2023, and downed its price target to $6. In a note dated December 01, 2022, Goldman initiated an Buy rating and provided a target price of $20 on this stock.
The stock price of Altimmune Inc [ALT] has been fluctuating between $5.14 and $11.16 over the past year. Currently, Wall Street analysts expect the stock to reach $23.6 within the next 12 months. Altimmune Inc [NASDAQ: ALT] shares were valued at $5.92 at the most recent close of the market. An investor can expect a potential return of 298.65% based on the average ALT price forecast.
Analyzing the ALT fundamentals
The Altimmune Inc [NASDAQ:ALT] reported sales of 0.02M for trailing twelve months, representing a drop of -86.49%. Gross Profit Margin for this corporation currently stands at -7.4% with Operating Profit Margin at -5158.6%, Pretax Profit Margin comes in at -4752.95%, and Net Profit Margin reading is -4752.95%. To continue investigating profitability, this company’s Return on Assets is posted at -0.68, Equity is -0.65 and Total Capital is -0.8. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.50 points at the first support level, and at 5.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.20, and for the 2nd resistance point, it is at 6.47.
Ratios To Look Out For
It’s worth pointing out that Altimmune Inc [NASDAQ:ALT]’s Current Ratio is 13.10. Also, the Quick Ratio is 13.10, while the Cash Ratio stands at 3.53. Considering the valuation of this stock, the price to sales ratio is 22796.00, the price to book ratio is 3.47.
Transactions by insiders
Recent insider trading involved WEAVER GREGORY L, Chief Financial Officer, that happened on Mar 13 ’25 when 10000.0 shares were purchased. Director, Drutz David completed a deal on Aug 19 ’24 to sell 16011.0 shares.
